The novel human coronavirus SARS-CoV-2 has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described, probably via droplets but possibly also via contaminated hands or surfaces. In a recent review on the persistence of human and veterinary coronaviruses on inanimate surfaces it was shown that human coronaviruses…
Infection Prevention in Practice Template
Write in a clean editor, then format for Infection Prevention in Practice in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Infection Prevention in Practice format
Infection Prevention in Practice is a peer-reviewed journal published by Elsevier, covering Infection Control in Healthcare, Nosocomial Infections in ICU, Antibiotic Use and Resistance.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Infection Prevention in Practice 12 (2023) 45–58.
Formats any DOI in Infection Prevention in Practice style. No sign-up. |
| Publishes research in | Infection Control in Healthcare Nosocomial Infections in ICU Antibiotic Use and Resistance Antibiotic Resistance in Bacteria Infection Control and Ventilation |
| ISSN | 2590-0889 |
| Citation impact (2-yr) | 2.32 |
| h-index | 27 |
| i10-index | 107 |
| Total citations | 3,960 |
| Article processing charge | $1,548 |
| Open access | Yes |
| Top institutions publishing here | University College London |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Infection Prevention in Practice per year
Citation impact of Infection Prevention in Practice by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Infection Prevention in Practice
From its origins as a left-field, experimental, and even "maverick" intervention, faecal microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving therapeutic strategy, for the management of recurrent Clostridiodes difficile infection (rCDI). It is being investigated as a treatment for a growing number of diseases including hepatic encephalopathy and eradication of antimicrobial resistant…
Hospital-acquired infections are on the rise and are a substantial cause of clinical and financial burden for healthcare systems. While infection control plays a major role in curtailing the spread of outbreak organisms, it is not always successful. One organism of particular concern is Acinetobacter baumannii, due to both its persistence in the hospital setting…
(CRAB) in a COVID-19 dedicated hospital. The suspected mechanism of transfer was an environmental source that persisted despite evacuation and terminal cleaning of the entire hospital, and transmitted through healthcare workers' hands or equipment. This outbreak demonstrates that practices to prevent the spread of multidrug-resistant organisms must not be neglected during the COVID-19 pandemic.
Peripheral intravenous catheters (PIVCs) are the most commonly used invasive medical device in health care with an overall failure rate of 35–50%. Most complications are non-infectious, but local site and bloodstream infections can also occur. Even if PIVC-related infections are rare, the total number of affected patients and the preponderance of Staphylococcus aureus as related…